Literature DB >> 15461632

Haemostasis.com: clinical experiences in the investigational use of rFVIIa in the management of severe haemorrhage.

C Kessler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15461632     DOI: 10.1111/j.1365-2141.2004.05171.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  Recombinant activated factor VII in controlling bleeding in non-hemophiliac patients.

Authors:  Farjah H AlGahtani; Mashael Alshaikh; AbdulRehman AlDiab
Journal:  Ann Saudi Med       Date:  2010 May-Jun       Impact factor: 1.526

2.  Preparation of factor VII concentrate using CNBr-activated Sepharose 4B immunoaffinity chromatography.

Authors:  Kamran Mousavi Hosseini; Saleh Nasiri
Journal:  Med J Islam Repub Iran       Date:  2015-01-28

3.  Life-Threatening Pulmonary Hemorrhage Responds to Recombinant Factor VIIa: A Case Series in South Florida Hospitals.

Authors:  Raiko Diaz; Patricia Almeida; Michael Alvarez; Gustavo Ferrer; Felix Hernandez
Journal:  Cureus       Date:  2019-11-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.